Native group‐III metabotropic glutamate receptors are coupled to the mitogen‐activated protein kinase/phosphatidylinositol‐3‐kinase pathways

Neurons 0303 health sciences MAP Kinase Signaling System Aminobutyrates Active Transport, Cell Nucleus Apoptosis beta-catenin; cerebellar granule cells; metabotropic glutamate receptors; mglu; mitogen-activated protein kinase (mapk); pi-3-kinase; protein kinase/phosphatidylinositol-3-kinase; β-catenin Protein Serine-Threonine Kinases Enzyme Activation Cytoskeletal Proteins Phosphatidylinositol 3-Kinases 03 medical and health sciences Neuroprotective Agents Excitatory Amino Acid Agonists Potassium Animals Enzyme Inhibitors Mitogen-Activated Protein Kinases Phosphorylation Excitatory Amino Acid Antagonists Cell Division Cells, Cultured Phosphoinositide-3 Kinase Inhibitors
DOI: 10.1046/j.1471-4159.2002.00929.x Publication Date: 2003-03-12T07:01:39Z
ABSTRACT
Abstract We used cultured cerebellar granule cells to examine whether native group‐III metabotropic glutamate (mGlu) receptors are coupled the mitogen‐activated protein kinase (MAPK) and phosphatidylinositol‐3‐kinase (PI‐3‐K) pathways. Cultured responded mGlu receptor agonist, L ‐2‐amino‐4‐phosphonobutanoate ( l ‐AP4), with an increased phosphorylation activity of MAPKs (ERK‐1 ‐2) PI‐3‐K target, B (PKB/AKT). These effects were attenuated by antagonists, α‐methyl‐serine‐ O ‐phosphate (MSOP) R,S )‐α‐cyclopropyl‐4‐phosphonophenylglycine (CPPG), or pretreatment cultures pertussis toxin. ‐AP4 also induced nuclear translocation β‐catenin, a downstream effector pathway. To assess functional relevance these mechanisms we examined ability protect against apoptosis trophic deprivation, lowering extracellular K + from 25 10 m . Neuroprotection was MSOP abrogated compounds PD98059 UO126 , which inhibit MAPK pathway, compound LY294002, inhibits Taken together, results show for first time that PI‐3‐K, activation both pathways is necessary neuroprotection mediated this particular class receptors.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (51)
CITATIONS (164)